BackEnlivex Therapeutics Overview
Enlivex Therapeutics Ltd

Enlivex Therapeutics Discounted Cash Flow

DCF Analysis for ENLV.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.03

Current Fair Value

$0.03
95.5% Downside

Overvalued by 95.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading